Sinomed announces positive safety and efficacy data from PIONEER III study
Ngày 18/11/2020 11:55 | Lượt xem: 770

Sinomed has announced the presentation of data from its inter-continental PIONEER III study comparing the safety and efficacy of the Supreme HT (healing-targeted) drug-eluting stent (DES), to the Xience (Abbott) or Promus durable polymer stent (Boston Scientific). One-year results were presented during a late-breaking trial session at the American Heart Association 2020 scientific sessions (AHA 2020, 13–17 November, virtual). The data showed equivalent clinical performance of the Supreme HT to the market-leading DES and will be used to support US Food and Drug Administration (FDA) and Japanese regulatory approvals.

The PIONEER III study enrolled 1,629 patients (randomised 2:1 experimental to control) from North America, Europe and Japan and had a primary composite endpoint of target lesion failure (TLF) at one-year. The TLF outcomes showed that the Supreme HT met the non-inferiority endpoint at 5.4% compared to 5.1% from the durable polymer DES (p=0.002). A grouped analysis of secondary endpoints showed a numerically better result for Supreme HT in cardiac death or target-vessel myocardial infarction (TV MI) with 3.5% in the Supreme HT arm compared to 4.6% in the control arm (p=0.27). Lower late stent thrombosis data (Supreme HT 0.1% compared to DP DES 0.4%, p=0.22) also suggested exceptional safety for the HT DES.  A powered, landmark TLF analysis evaluating the healing superiority of Supreme HT between one and five years is ongoing.

“I am very pleased that Japanese patients will benefit from the most advanced DES in the US, Europe and Japan,” said Shigeru Saito, Shonan Kamakura General, Kamakura, Japan and primary investigator of the Japanese cohort of the PIONEER III study . “The results combined with the safety measurement of cardiac death, target vessel MI and late stent thrombosis favour the Supreme HT, supporting the early endothelial healing concept.”

The Supreme HT development was based on the “wound-healing window” concept originally proposed in 2013 and represents a novel class of DES that highlight the importance of early, timely healing, Sinomed said in a press release.

“We are very grateful to the extraordinary group of medical professionals and all the patients who have endured through this difficult pandemic and completed this study milestone in such a timely and professional manor,” said Jianhua Sun, chairman & chief executive officer of Sinomed. “The results have been extremely encouraging and if we reach superiority in the landmark analysis, we could revolutionise the understanding of healing and the future of implantable devices.”

Source CardiovascularNews

Duc Tin Clinic

 

Print Chia sẽ qua facebook bài: Sinomed announces positive safety and efficacy data from PIONEER III study Chia sẽ qua google bài: Sinomed announces positive safety and efficacy data from PIONEER III study Chia sẽ qua twitter bài: Sinomed announces positive safety and efficacy data from PIONEER III study Chia sẽ qua MySpace bài: Sinomed announces positive safety and efficacy data from PIONEER III study Chia sẽ qua LinkedIn bài: Sinomed announces positive safety and efficacy data from PIONEER III study Chia sẽ qua stumbleupon bài: Sinomed announces positive safety and efficacy data from PIONEER III study Chia sẽ qua icio bài: Sinomed announces positive safety and efficacy data from PIONEER III study Chia sẽ qua digg bài: Sinomed announces positive safety and efficacy data from PIONEER III study Chia sẽ qua yahoo bài: Sinomed announces positive safety and efficacy data from PIONEER III study Chia sẽ qua yahoo bài: Sinomed announces positive safety and efficacy data from PIONEER III study Chia sẽ qua yahoo bài: Sinomed announces positive safety and efficacy data from PIONEER III study Chia sẽ qua yahoo bài: Sinomed announces positive safety and efficacy data from PIONEER III study

Tin tức liên quan

CUSTOMER REVIEWS

  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search
Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389

TOP